Clinical Center News
Summer 2020

Join a clinical trial at the NIH Clinical Center and pave a path forward for research, science and healthcare

For more information on trials listed below, or to learn about other available opportunities to participate in research studies, call the NIH Clinical Center Office of Patient Recruitment 1- 866-444-2214, TTY: 1-866-411-1010. Or email prpl@cc.nih.gov. Se habla español.

NHLBI seeks adults with severe aplastic anemia (SAA) for a research study determining viability and safety of early initiation of oral therapy with cyclosporine and eltrombopag in patients with SAA. All patients will receive standard treatment with cyclosporine, eltrombopag, and Horse Anti-thymocyte-Globulin (h-ATG) unless there is complete count recovery with oral therapy. Compensation will be provided. Refer to Study 20-H-0033.

medical graphic

NIDDK researchers seek healthy volunteers (18-45 years old) to participate in a study investigating how dopamine affects body weight and eating behavior. Participants must be able to visit the Clinical Center for 5 consecutive days to pick up food and then have a 5-day inpatient stay. Refer to Study 18-DK-0132.

Scale surrounded by junk food

NHLBI seeks patients with clonal hematopoiesis of indeterminate potential (CHIP). Patients with CHIP have a genetic mutation that has been associated with blood cancer. The study will look at CHIP and try to determine its relationship to blood cancers and heart disease. The study will also try to discover other new organs or diseases that may be linked with. There is no charge for study-related tests, medications or procedures. Travel assistance may be provided. Refer to Study 19-H-0139.

drop of blood with magnifying glass

NHLBI seeks patients with Clonal Cytopenia of Uncertain Significance (CCUS). Patients with CCUS have low blood counts and a normal bone marrow exam but more advanced genetic testing shows the presence of a genetic mutation that is likely causing the low counts. The study will look at CCUS and try to determine its relationship to blood cancers and heart disease. The study will also try to discover other new organs or diseases it may be linked with There is no charge for study-related tests, medications or procedures. Travel assistance may be provided. Refer to Study 19-H-0139.

magnifying glass with blood cells in view

NHLBI researchers seek COVID-19 positive patients in the DMV area for a new clinical trial. The study hopes to help researchers understand how coronavirus affects the function of the body's immune system in controlling the infection. Additionally, researchers want to understand how different organs of the body (such as the lungs, heart, brain, and kidneys) respond to the infection from its early appearance to recovery, and whether there are any long-term effects of the infection on the organs of the body. All medical care is at no cost to the participant and compensation for the entire study is provided. Contact NATHX_COVID@nih.gov for more information on the study.

A woman wearing mask walking down sidewalk.

NHLBI the National Institutes of Health (NIH) in Bethesda, Maryland are conducting an investigational treatment study with eltrombopag to help patients with Diamond-Blackfan anemia (DBA). Refer to Study 20-H-0021.

blood cells

NICHD study seeks children 2-18 years old with growth hormone excess to participate in a research study. Researchers want to see if pegvisomant, a drug that antagonizes growth hormone action, can help children and adolescents with gigantism. Refer to Study 19-CH-0071.

Human growth hormone chart

NINR invites cancer survivors or those with chronic illnesses such as myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), Sjogren's disease, or Lupus to participate in a research study on fatigue. Researchers want to test if a one-time dose of the medication Ketamine or a similar drug can reduce fatigue. This is not a treatment study for fatigue, cancer, ME, CFS, Sjogren's disease, or Lupus. Please note that NINR employees/staff or their immediate family members are not eligible to participate. Refer to Study 20-NR-0003.

- Submitted by the NIH Clinical Center Office of Patient Recruitment

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at https://www.cc.nih.gov/disclaimers.html